- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.10. | Ramping up for FDA submission, Ironwood makes further bid for $1B GI drug with subgroup data | ||
| 28.10. | BMS and UT San Antonio win $615k government grant to develop green pharma manufacturing processes | ||
| 28.10. | Ottimo Pharma exits stealth with former Seagen CEO at the helm and 'exquisitely designed' cancer candidate in its pocket | ||
| 28.10. | TCT 2024: Studies show early TAVR procedures help prevent later hospitalizations | ||
| 28.10. | AbbVie inks $1.4B Aliada buyout, landing ex-J&J Alzheimer's drug to leap the blood-brain barrier | ||
| 28.10. | Analysts hail Vera's kidney drug as potential 'functional cure' as benefits persist to Week 96 | ||
| 25.10. | Dexcom posts mixed-bag earnings report amid Stelo rollout, CCO departure | ||
| 25.10. | Irish CRO giant Icon plots layoffs after underwhelming Q3 performance | ||
| 25.10. | FDA approves Medtronic's Affera all-in-one pulsed field ablation system | ||
| 25.10. | Two new drugs reduce cryptosporidiosis parasite numbers in infected mice and calves | ||
| 25.10. | Septerna's $288M IPO is another sign of the market warming to biotech investment | ||
| 25.10. | AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator | ||
| 25.10. | GenSight enters final weeks of cash runway as revenue stream edges out of reach | ||
| 24.10. | Monopar retrieves Wilson disease candidate from AstraZeneca's scrap heap | ||
| 24.10. | Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say | ||
| 24.10. | Medtronic expands reach of its latest TAVR valve with European approval | ||
| 24.10. | Poseida's HAE gene therapy edits primate livers and reduces kallikrein protein levels in mice, company says | ||
| 24.10. | Eisai, Eli Lilly didn't disclose heightened brain injury risk to Alzheimer's trial patients: NYT | ||
| 24.10. | Biocon accused of committing IP theft to create cancer biotech Bicara | ||
| 24.10. | Roche expands Dyno gene therapy collab, bets up to $1B-plus that AI can help design better delivery tools | ||
| 24.10. | Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks in phase 2 | ||
| 24.10. | Lundbeck slashes value of $250M Abide buyout after pain setback | ||
| 23.10. | As clinical trials rise globally, Europe's share of the pie has shrunk: IQVIA report | ||
| 23.10. | Boston Scientific posts 177% EP growth, pauses Farapulse study in first-line afib | ||
| 23.10. | Alpha-9 raises $175M series C to bankroll clinical-stage radiopharma pipeline |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
